Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 38 peer-reviewed journal articles Updated
Gynecology · Uterine Corpus Leiomyomas

Why Are Fibroids More Common and Severe in Black Women?

At a Glance

Black women are diagnosed with uterine fibroids more often and often at younger ages, and may have larger or more numerous tumors. These differences reflect genetic, environmental, healthcare access, and systemic factors; evaluation should include anemia testing, imaging, and fertility goals.

In this answer

3 sections

01

Understanding Your Fibroids

02

A Multifactorial Condition

03

Advocating for the Care You Deserve

Uterine corpus leiomyomas—commonly known as fibroids—are common, usually non-cancerous (benign) growths of the uterine muscle. Black women are disproportionately affected by uterine fibroids, experiencing a prevalence roughly two to three times higher than White women [1][2]. At a population level, diagnosis in Black women often happens at a younger age, and the fibroids can be larger and more numerous [3][4]. Consequently, Black women often endure a heavier symptom burden, particularly severe heavy menstrual bleeding and iron-deficiency anemia [5].

It is important to understand that these population-level disparities do not dictate your individual journey. Furthermore, these disparities are not simply due to biological race. Instead, they result from a complex mix of genetics, environmental exposures, healthcare access barriers, and systemic bias [5][6].

Urgent Care Warning

Heavy bleeding and severe anemia can become medical emergencies. Seek urgent or emergency care immediately if you are rapidly soaking through pads or tampons (e.g., more than one per hour), if you experience fainting or near-fainting, severe weakness, shortness of breath, chest pain, a racing heartbeat, or severe, sudden pelvic pain [7][8]. If there is any chance you might be pregnant and you begin bleeding heavily, seek immediate medical assessment [7]. Do not wait for a routine fibroid appointment.

Understanding Your Fibroids

Fibroids are categorized by where they grow, which strongly affects your symptoms, fertility, and treatment choices [9]:

  • Submucosal: Bulging into the uterine cavity; heavily linked to severe bleeding and fertility issues.
  • Intramural: Growing within the muscular wall of the uterus.
  • Subserosal: Growing on the outside of the uterus; often causing pelvic pressure.

A Multifactorial Condition

The reasons behind the disparity in fibroid severity are not entirely understood, but current evidence points to several interacting factors.

Biology and Genetics

Studies suggest differences in genetic ancestry and molecular susceptibilities (specific traits within cells) that may precede the formation of the tumors [10][11]. However, these are overlapping vulnerabilities, not a single established racial biological difference [5]. Metabolic factors, such as a higher body mass index (BMI, a measure of body size) and insulin resistance, are also linked to higher fibroid risk and may interact with genetics [12][13].

Environmental Exposures and Nutrition

  • Vitamin D Deficiency: Lower levels of vitamin D in the blood are consistently associated with the presence of fibroids [14]. While some studies suggest supplementation might inhibit fibroid growth [15], it is not a proven cure. You should not self-treat with high-dose supplements without clinical advice.
  • Chemical Exposures: Exposure to endocrine-disrupting chemicals—substances like phthalates in plastics that interfere with hormones—may be linked to fibroid development [16][17].
  • Life Stress: Chronic stress, often measured as allostatic load (the physical wear and tear on the body from prolonged stress), is considered a plausible framework for understanding why Black women face higher fibroid burdens [6].

Note: Stress, BMI, and environmental exposures are largely associations, not established direct causes. You did not cause your fibroids, and these factors should not be used to blame patients.

Systemic Bias and Healthcare Access

The disparity extends into how patients interact with the healthcare system. Mistrust of the medical system is a rational response to historical discrimination and documented ongoing inequities [18][19]. Structural barriers—such as lack of transportation, high costs, scheduling delays, and limited access to highly skilled gynecologic surgeons—mean that fibroids are often diagnosed later or managed less effectively [5][20][21].

When Black women do receive care, treatment pathways can differ. For example, some data shows Black veterans with smaller uteruses are less likely to receive minimally invasive hysterectomies than White veterans [22], and there are geographic differences in access to certain uterus-preserving options [23].

Advocating for the Care You Deserve

Because of the documented disparities, self-advocacy is critical. You have the right to a comprehensive evaluation and a voice in your treatment plan.

What Care You Should Expect

Your evaluation should include:

  • Thorough Symptom Review: An assessment connecting your bleeding and pain to your quality of life [9]. Fibroids can coexist with other conditions like polyps, adenomyosis, thyroid disease, or endometrial disease. Your doctor may perform a pelvic exam, a pregnancy test if relevant, and an endometrial biopsy based on your age and bleeding pattern to rule out other causes [24][25][26].
  • Blood Tests for Anemia: Heavy bleeding is closely tied to iron deficiency. Expect a CBC (complete blood count) to measure hemoglobin and check for anemia, and a ferritin test to measure your body’s iron stores [24][27]. Treatment plans for iron deficiency are highly individualized, ranging from oral iron pills to intravenous (IV) iron [28].
  • Detailed Imaging: A transvaginal ultrasound is the standard first imaging step [29]. If ultrasound is inconclusive, if your anatomy is complex, or if detailed mapping is needed for surgical planning, an MRI or sonohysterography (ultrasound with fluid in the uterus) may be considered [30][31].

Treatment Options: Uterus-Preserving vs. Fertility-Preserving

You should discuss all reasonable options for your specific situation. Preserving your uterus is not the same thing as preserving your ability to carry a pregnancy.

  • Symptom-Directed Medications: Medicines like tranexamic acid, NSAIDs, hormonal treatments (like a levonorgestrel IUD), and GnRH medicines can help control heavy bleeding and pain [32][9]. These manage symptoms but do not remove the fibroids.
  • Fertility-Preserving Surgery: Myomectomy (surgical removal of just the fibroids) is generally the preferred procedural approach if future pregnancy is an important goal, depending on the fibroids’ size and location [33].
  • Uterus-Preserving (Limited Fertility Evidence): Procedures like Uterine Artery Embolization (UAE) (blocking blood flow to fibroids) and Radiofrequency Ablation (RFA) (using heat to shrink fibroids) keep the uterus in place [34]. However, evidence regarding their impact on future pregnancy is uncertain or limited [35].
  • Definitive Treatment: A Hysterectomy removes the entire uterus. It permanently stops menstrual bleeding and fibroid growth, but eliminates the ability to carry a pregnancy [33].

Note: Any procedure that leaves the uterus in place carries a risk of reintervention, meaning you might need another procedure later if symptoms return [36].

Tips for Self-Advocacy

  • Bring Your Records: Track how many pads or tampons you soak through, clot size, and days of work missed.
  • Request Specialists: Ask for a referral to a minimally invasive gynecologic surgeon (a doctor who specializes in complex uterine surgery using small incisions) or an interventional radiologist [37].
  • Know Your Goals: Be upfront about whether you want to carry a pregnancy in the future, as this heavily dictates which treatments are safe [9][38].

Common questions in this guide

Why are uterine fibroids more common and more severe in Black women?
Population studies find that Black women are diagnosed with fibroids more often, often at younger ages, and may have larger or more numerous tumors. The difference is not explained by biological race alone; genetic ancestry, environmental and metabolic factors, chronic stress, healthcare access barriers, and systemic bias may all contribute. These patterns do not determine what will happen in one person, and you did not cause your fibroids.
When should heavy bleeding from fibroids be treated as an emergency?
Seek emergency care if you rapidly soak through more than one pad or tampon per hour, faint or nearly faint, or have severe weakness, shortness of breath, chest pain, a racing heartbeat, or sudden severe pelvic pain. Heavy bleeding during a possible pregnancy also needs immediate assessment; do not wait for a routine fibroid appointment.
What tests are commonly used to evaluate fibroids and anemia?
Your evaluation may include a symptom review, pelvic exam, pregnancy test when relevant, a complete blood count to check hemoglobin, a ferritin test to measure iron stores, and a transvaginal ultrasound. MRI or sonohysterography may be recommended when ultrasound is unclear or detailed mapping is needed, and an endometrial biopsy may be considered based on your age and bleeding pattern to look for other causes.
Which fibroid treatment is usually considered when I want to become pregnant?
Myomectomy removes fibroids while leaving the uterus and is generally the preferred procedure when future pregnancy is important, depending on fibroid size and location. Uterine artery embolization and radiofrequency ablation leave the uterus in place, but evidence about pregnancy after these treatments is limited or uncertain, so discuss them with a gynecologic specialist.
Does keeping my uterus mean I can still carry a pregnancy?
No. Uterus-preserving procedures keep the uterus but do not all have proven safety for future pregnancy, while a hysterectomy permanently removes the ability to carry a pregnancy. Ask your clinician to separate your goal of keeping the uterus from your goal of preserving fertility when comparing options.
Which specialists can help me compare complex fibroid treatments?
A gynecologist, especially a minimally invasive gynecologic surgeon, can review surgical options and complex uterine anatomy. An interventional radiologist can discuss uterine artery embolization; asking for both perspectives may help you compare recovery, fertility implications, and the chance of needing another procedure.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Related questions

What Do Hybrid FIGO 2-5, 3-5, or 2-6 Uterine Fibroids Mean? When is Heavy Bleeding from Uterine Fibroids an Emergency? When Should I Have MRI, SIS, or Hysteroscopy for Fibroids? Can Uterine Fibroids Cause Fatigue and Shortness of Breath? When Is Severe Uterine Fibroid Pain or Fever an Emergency?
Show more
Can Uterine Fibroids Cause Painful Sex or Sexual Changes? Can Fibroids Cause Abdominal Enlargement or Weight Gain? Do I Need an Endometrial Biopsy for Fibroid Bleeding? Does Rapid Fibroid Growth Mean Uterine Cancer? Signs to Know How Is Postmenopausal Bleeding Evaluated With Fibroids? How Are Cavity-Distorting Fibroids Treated Before IVF? What Blood Tests Are Needed for Anemia From Fibroids? Do Uterine Fibroids Become Cancerous or Raise Cancer Risk? Can Fibroids Cause Constipation, Bloating or Urinary Issues? Can Asymptomatic Uterine Fibroids Be Safely Left Untreated? Do Uterine Fibroids Run in Families? Screening Advice Do Uterine Fibroids Shrink Before or After Menopause? Can Diet, Exercise, or Supplements Shrink Fibroids? How Are Fibroids Distinguished from Other Pelvic Conditions?

Get notified when new evidence is published on uterine corpus leiomyoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my symptom log, what specific blood tests like a CBC and ferritin should we run, and what is our plan to restore my iron if it is low?
  2. 2.If my ultrasound is inconclusive, would an MRI or sonohysterography help map my fibroids for treatment planning?
  3. 3.Can you explain which of these treatment options preserves my uterus, and specifically which ones are safe if I want to carry a pregnancy in the future?
  4. 4.What is the expected recovery time and the reintervention risk (chance of needing another procedure later) for the options we are discussing?
  5. 5.Can you refer me to a minimally invasive gynecologic surgeon or an interventional radiologist to explore all reasonable options for my specific fibroid locations?

References

References (38)
  1. 1

    Epidemiology of uterine fibroids: a systematic review.

    Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R

    BJOG : an international journal of obstetrics and gynaecology 2017; (124(10)):1501-1512 doi:10.1111/1471-0528.14640.

    PMID: 28296146
  2. 2

    A multi-stage genome-wide association study of uterine fibroids in African Americans.

    Hellwege JN, Jeff JM, Wise LA, et al.

    Human genetics 2017; (136(10)):1363-1373 doi:10.1007/s00439-017-1836-1.

    PMID: 28836065
  3. 3

    Uterine fibroids with heavy menstrual bleeding stratified by race in a commercial and Medicaid database.

    Agarwal SK, Stokes M, Chen R, Lickert C

    AJOG global reports 2024; (4(4)):100412 doi:10.1016/j.xagr.2024.100412.

    PMID: 39559275
  4. 4

    Uterine Fibroids in Black Women: A Race-Stratified Subgroup Analysis of Treatment Outcomes After Laparoscopic Radiofrequency Ablation.

    Berman JM, Bradley L, Hawkins SM, Levy B

    Journal of women's health (2002) 2022; (31(4)):593-599 doi:10.1089/jwh.2020.9001.

    PMID: 34287028
  5. 5

    Racial disparities in uterine fibroids and endometriosis: a systematic review and application of social, structural, and political context.

    Katon JG, Plowden TC, Marsh EE

    Fertility and sterility 2023; (119(3)):355-363 doi:10.1016/j.fertnstert.2023.01.022.

    PMID: 36682686
  6. 6

    Allostatic load and uterine fibroids: role in pathogenesis and racial disparities.

    Chern R, Michel R, Nothnick WB, et al.

    Uterine research 2026; (1(1)):2 doi:10.1186/s44494-026-00002-0.

    PMID: 42565046
  7. 7

    Intra-abdominal haemorrhage from uterine fibroids: a systematic review of the literature.

    Lim WH, Cohen SC, Lamaro VP

    BMC surgery 2020; (20(1)):70 doi:10.1186/s12893-020-00736-5.

    PMID: 32293414
  8. 8

    Hypovolaemic shock due to intra-abdominal haemorrhage from multiple uterine fibroids.

    Takaki E, Goto M, Hori K, Ito K

    BMJ case reports 2021; (14(5)) doi:10.1136/bcr-2021-241782.

    PMID: 34049894
  9. 9

    Guideline No. 461: The Management of Uterine Fibroids.

    Chen I, Kives S, Randle E, et al.

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2025; (47(8)):102970 doi:10.1016/j.jogc.2025.102970.

    PMID: 40562356
  10. 10

    Transcriptome and DNA methylome analyses reveal underlying mechanisms for the racial disparity in uterine fibroids.

    Paul EN, Grey JA, Carpenter TJ, et al.

    JCI insight 2022; (7(20)).

    PMID: 36066972
  11. 11

    Epigenomic and enhancer dysregulation in uterine leiomyomas.

    Mlodawska OW, Saini P, Parker JB, et al.

    Human reproduction update 2022; (28(4)):518-547 doi:10.1093/humupd/dmac008.

    PMID: 35199155
  12. 12

    African genetic ancestry interacts with body mass index to modify risk for uterine fibroids.

    Giri A, Edwards TL, Hartmann KE, et al.

    PLoS genetics 2017; (13(7)):e1006871 doi:10.1371/journal.pgen.1006871.

    PMID: 28715450
  13. 13

    Genetic liability to multiple factors and uterine leiomyoma risk: a Mendelian randomization study.

    Qu Y, Chen L, Guo S, et al.

    Frontiers in endocrinology 2023; (14()):1133260 doi:10.3389/fendo.2023.1133260.

    PMID: 37576957
  14. 14

    A Systematic Review of Vitamin D and Fibroids: Pathophysiology, Prevention, and Treatment.

    Combs A, Singh B, Nylander E, et al.

    Reproductive sciences (Thousand Oaks, Calif.) 2023; (30(4)):1049-1064 doi:10.1007/s43032-022-01011-z.

    PMID: 35960442
  15. 15

    Hypovitaminosis D and "small burden" uterine fibroids: Opportunity for a vitamin D supplementation.

    Ciavattini A, Delli Carpini G, Serri M, et al.

    Medicine 2016; (95(52)):e5698 doi:10.1097/MD.0000000000005698.

    PMID: 28033263
  16. 16

    The role of endocrine-disrupting chemicals in uterine fibroid pathogenesis.

    Bariani MV, Rangaswamy R, Siblini H, et al.

    Current opinion in endocrinology, diabetes, and obesity 2020; (27(6)):380-387 doi:10.1097/MED.0000000000000578.

    PMID: 33044243
  17. 17

    Metals and metal mixtures associated with the odds of uterine fibroid prevalence among African Caribbean women in the Tobago Health Study.

    Kiyanda A, Mazumder H, Miljkovic I, et al.

    Frontiers in reproductive health 2026; (8()):1917571 doi:10.3389/frph.2026.1917571.

    PMID: 42676664
  18. 18

    Perceptions of Ethnoracial Factors in the Management and Treatment of Uterine Fibroids.

    Orellana M, Riggan KA, DSouza K, et al.

    Journal of racial and ethnic health disparities 2022; (9(4)):1184-1191 doi:10.1007/s40615-021-01059-8.

    PMID: 34013445
  19. 19

    The impact of health literacy on uterine fibroid awareness, diagnosis, and treatment in the United States: a mini literature review.

    Evans J

    Frontiers in reproductive health 2024; (6()):1335412 doi:10.3389/frph.2024.1335412.

    PMID: 38529318
  20. 20

    The role of socioeconomic status in uterine fibroid awareness and treatment: a narrative review.

    Evans J, Jones K

    Therapeutic advances in reproductive health 2024; (18()):26334941241297634 doi:10.1177/26334941241297634.

    PMID: 39525322
  21. 21

    Enhancing Uterine Fibroid Care: Clinician Perspectives on Diagnosis, Disparities, and Strategies for Improving Health Care.

    Laily A, Nair I, Shank SE, et al.

    Women's health reports (New Rochelle, N.Y.) 2024; (5(1)):293-304 doi:10.1089/whr.2023.0113.

    PMID: 38558944
  22. 22

    Uterine Weight as a Modifier of Black/White Racial Disparities in Minimally Invasive Hysterectomy Among Veterans with Fibroids in the Veterans Health Administration.

    Carey CM, Katon JG, Bossick AS, et al.

    Health equity 2022; (6(1)):909-916 doi:10.1089/heq.2022.0130.

    PMID: 36636115
  23. 23

    Racial Disparities in Uterine Fibroid Treatment Among Veterans Using VA Health Care.

    Katon JG, Bossick A, Carey C, et al.

    Women's health issues : official publication of the Jacobs Institute of Women's Health 2023; (33(4)):405-413 doi:10.1016/j.whi.2023.03.005.

    PMID: 37105835
  24. 24

    Abnormal Uterine Bleeding.

    Lebduska E, Beshear D, Spataro BM

    The Medical clinics of North America 2023; (107(2)):235-246 doi:10.1016/j.mcna.2022.10.014.

    PMID: 36759094
  25. 25

    New Light on Endometrial Thickness as a Risk Factor of Cancer: What Do Clinicians Need to Know?

    Saccardi C, Spagnol G, Bonaldo G, et al.

    Cancer management and research 2022; (14()):1331-1340 doi:10.2147/CMAR.S294074.

    PMID: 35401014
  26. 26

    Premenopausal abnormal uterine bleeding and risk of endometrial cancer.

    Pennant ME, Mehta R, Moody P, et al.

    BJOG : an international journal of obstetrics and gynaecology 2017; (124(3)):404-411 doi:10.1111/1471-0528.14385.

    PMID: 27766759
  27. 27

    Anemia Secondary to Abnormal Uterine Bleeding Requiring Blood Transfusion in the Reproductive Age Group-A Retrospective Study.

    Santhosh A, Jesrani S, Al Mahruki J, et al.

    Life (Basel, Switzerland) 2026; (16(5)) doi:10.3390/life16050855.

    PMID: 42195410
  28. 28

    The modern management of uterine fibroids-related abnormal uterine bleeding.

    Vannuccini S, Petraglia F, Carmona F, et al.

    Fertility and sterility 2024; (122(1)):20-30 doi:10.1016/j.fertnstert.2024.04.041.

    PMID: 38723935
  29. 29

    A pictorial review of ultrasonography of the FIGO classification for uterine leiomyomas.

    Bajaj S, Gopal N, Clingan MJ, Bhatt S

    Abdominal radiology (New York) 2022; (47(1)):341-351 doi:10.1007/s00261-021-03283-6.

    PMID: 34581926
  30. 30

    ACR Appropriateness Criteria® Abnormal Uterine Bleeding.

    , Robbins JB, Sadowski EA, et al.

    Journal of the American College of Radiology : JACR 2020; (17(11S)):S336-S345 doi:10.1016/j.jacr.2020.09.008.

    PMID: 33153547
  31. 31

    Clinical signs and diagnosis of fibroids from adolescence to menopause.

    Mension E, Carmona F, Vannuccini S, Chapron C

    Fertility and sterility 2024; (122(1)):12-19 doi:10.1016/j.fertnstert.2024.05.003.

    PMID: 38729337
  32. 32

    GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

    Ferrero S, Gazzo I, Perrone U, et al.

    Expert opinion on pharmacotherapy 2026; (27(11)):1163-1178 doi:10.1080/14656566.2026.2695094.

    PMID: 42360331
  33. 33

    Uterine-Artery Embolization or Myomectomy for Uterine Fibroids.

    Manyonda I, Belli AM, Lumsden MA, et al.

    The New England journal of medicine 2020; (383(5)):440-451 doi:10.1056/NEJMoa1914735.

    PMID: 32726530
  34. 34

    Three-Year Results of the SONATA Pivotal Trial of Transcervical Fibroid Ablation for Symptomatic Uterine Myomata.

    Lukes A, Green MA

    Journal of gynecologic surgery 2020; (36(5)):228-233 doi:10.1089/gyn.2020.0021.

    PMID: 33061253
  35. 35

    Reproductive and Obstetric Outcomes after UAE, HIFU, and TFA of Uterine Fibroids: Systematic Review and Meta-Analysis.

    Akhatova A, Aimagambetova G, Bapayeva G, et al.

    International journal of environmental research and public health 2023; (20(5)) doi:10.3390/ijerph20054480.

    PMID: 36901489
  36. 36

    Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis.

    Sandberg EM, Tummers FHMP, Cohen SL, et al.

    Fertility and sterility 2018; (109(4)):698-707.e1 doi:10.1016/j.fertnstert.2017.11.033.

    PMID: 29653718
  37. 37

    Patient Recommendations for Shared Decision-Making in Uterine Fibroid Treatment Decisions.

    Riggan KA, Stewart EA, Balls-Berry JE, et al.

    Journal of patient experience 2021; (8()):23743735211049655 doi:10.1177/23743735211049655.

    PMID: 34692992
  38. 38

    Uterine Fibroids: Diagnosis and Treatment.

    De La Cruz MS, Buchanan EM

    American family physician 2017; (95(2)):100-107.

    PMID: 28084714

This page is for informational purposes only and does not constitute medical advice. A gynecologist should evaluate your bleeding, anemia, fertility goals, and treatment options, and urgent symptoms require immediate care.